BioSpace News Archive

Business

Zymeworks Provides Corporate Update and Reports First Quarter 2022 Financial Results

Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today reported financial results for the first quarter ended March 31, 2022.

May 4, 2022
·
16 min read
Drug Development

First Patient Dosed in Phase II Renal Cancer Theranostics Study

Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that a first patient has been dosed in the ‘STARLITE 2' Phase II study of the Company’s investigational renal cancer therapy, TLX250 (177Lu-DOTA-girentuximab), at Memorial Sloan Kettering Cancer Center (MSK) in New York.

May 4, 2022
·
5 min read
Business

CONMED Corporation Announces First Quarter 2022 Financial Results

CONMED Corporation announced financial results for the first quarter ended March 31, 2022.

May 4, 2022
·
11 min read
Business

Schrödinger Reports First Quarter 2022 Financial Results

Schrödinger, Inc., whose physics-based software platform is transforming the way therapeutics and materials are discovered, announced financial results for the first quarter of 2022.

May 4, 2022
·
14 min read
Business

STAAR Surgical Reports Record First Quarter Net Sales of $63.2 Million Up 25% Y/Y

STAAR Surgical Company reported financial results for the first quarter ended April 1, 2022.

May 4, 2022
·
14 min read
Business

Ligand Reports First Quarter 2022 Financial Results

Ligand Pharmaceuticals Incorporated reported financial results for the three months ended March 31, 2022 and provided an operating forecast and program updates.

May 4, 2022
·
28 min read
Business

Acorda First Quarter 2022 Update: Webcast/Conference Call Scheduled for May 11, 2022

Acorda Therapeutics, Inc. will host a webcast/conference call in conjunction with its first quarter 2022 update and financial results on Wednesday, May 11 at 4:30 p.m. ET.

May 4, 2022
·
4 min read
Business

Nephros Announces Results for Quarter Ended March 31, 2022

Nephros, Inc. announced financial results for the first quarter ended March 31, 2022.

May 4, 2022
·
10 min read
Business

Acadia Pharmaceuticals Reports First Quarter 2022 Financial Results

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD), today announced its financial results for the first quarter ended March 31, 2022.

May 4, 2022
·
9 min read
Business

NANOBIOTIX to Announce First Quarter 2022 Financial Results on May 18, 2022

NANOBIOTIX announced that it will report its financial results for the first quarter of 2022 ending March 31, 2022, on Wednesday, May 18, 2022, after the close of the US market.

May 4, 2022
·
7 min read